Washington D.C., District of Columbia
CNS trials open to children and teens in Washington D.C., DC
10 CNS studies open to children and teens are recruiting participants at sites in Washington D.C. as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Washington D.C. at a glance
- 10 studies are recruiting at a site in Washington D.C..
- By phase: Phase 1 (1), Phase 3 (6), No phase (3). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (7), university, hospital or other (3).
- By research area: Migraine (5), Depression (3), ADHD (1), Schizophrenia (1).
- Most recent update to one of these records: November 3, 2026.
ADHD studies recruiting in Washington D.C.
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
- No phase
- Ages 8 to 16
- All sexes
- Sponsor
- Children's National Research Institute
- Study site
- Children's National Hospital
- Registry record
- NCT05099874 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Depression studies recruiting in Washington D.C.
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Children's National Medical Center
- Registry record
- NCT07227454 · updated
Does Social Media Impact Adolescent Mental Health?
- No phase
- Ages 10 to 14
- All sexes
- Sponsor
- Georgetown University
- Study site
- Georgetown University
- Registry record
- NCT06049888 · updated
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
- No phase
- Ages 13 to 17
- All sexes
- Sponsor
- Children's National Research Institute
- Study site
- Children's National Hospital
- Registry record
- NCT06618027 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Migraine studies recruiting in Washington D.C.
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Children's National Medical Center
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Children's National Medical Center
- Registry record
- NCT04743141 · updated
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Velocity Clinical Research, Washington DC
- Registry record
- NCT05156398 · updated
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Phase 1
- Ages 6 to 11
- All sexes
- Sponsor
- Pfizer
- Study site
- Velocity Clinical Research, Washington DC
- Registry record
- NCT06995729 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Emerson Clinical Research Institute - Connecticut Avenue - Washington /ID# 231693
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Schizophrenia studies recruiting in Washington D.C.
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigator Site
- Registry record
- NCT05303064 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Ask about studies near Washington D.C.
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections